Exogenous Melatonin in Postmenopausal Women With Insomnia
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the effect of exogenous melatonin, 2 mg SR, 60 minutes
before bedtime for 15 days, on the sleep and circadian rhythms of postmenopausal women with
insomnia in a randomized crossover placebo-controlled study.